Pancreatic cancer: Advances and challenges

Halbrook, Christopher J., Lyssiotis, Costas A., Pasca di Magliano, Marina, Maitra, Anirban·2023·Cell

Cited by (999)

Items 801–900 of 999

  1. Preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma using MRI-derived whole-tumor ADC histogram analysis
    Kun Chen, Mei Yong, Maoli Xu, Shihan Shi, Geya Tang, Yu-Feng Wang, Min Li, Yujie Wang, Xingzheng Pan, Zhibing Ruan · 2026 · Frontiers in Medicine
  2. Pancreatic Cancer Stem Cells Co-Expressing SOX2, OCT4, and TERThigh Represent an Aggressive Subpopulation
    Erika Curiel-Gomez, Dámaris P. Romero‐Rodríguez, Mauricio Rodríguez‐Dorantes, Vilma Maldonado, Jorge Meléndez-Zajgla · 2026 · Cells
  3. Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers
    Julian Frädrich, Carmen Mota Reyes, Michel Hendel, Vanessa Brunner, Batu Toledo, Damjan Manevski, Alexander Sommer, Daniel Häußler, Dominik Beck, Daniele Lucarelli et al. · 2026 · Cell Reports Medicine
  4. The multiple roles of the disordered protein CCDC6 in cancer development
    Guifeng Wei, Yiji Chen, Yichao Kong, Donglai Li, Yang Wang, Ting Qiu, Xiabin Chen · 2026 · International Journal of Cancer
  5. Utility of pancreatic tumor scrapings for organoid development and precision medicine strategies
    Caitlin Tsang, Hardik Patel, Fatim M. Kouassi, Binny Khandakar, Luce St. Surin, James A. Rouse, Raditya Utama, Deepthi Poornima Budagavi, Julien T. Hohenleitner, Adeline Chunton et al. · 2026 · The Journal of Pathology
  6. Phosphorylation-dependent STAMBP drives the progression of pancreatic ductal adenocarcinoma by deubiquitinating and stabilizing BAG3
    Yongkang Shi, Jun Gong, Lin Chen, Min Zhou, Shutao Pan, Taoyuan Yin, Chunle Zhao, Yuhui Liu, Zhenxiong Zhang, Yu Bai et al. · 2026 · Cell Death and Differentiation
  7. Mast cell corticotropin-releasing factor receptor 1 contributes to pancreatic cancer pain via mitogen-activated protein kinase/sphingosine kinases type 1 signaling
    Yue Zhang, Kai Wei, Kunming Tao, Min Ma, Zhijie Lu · 2026 · Pain
  8. Development of an Innovative Parallel Robot Used in Laparoscopic Pancreatic Surgery
    Alexandru Pusca, Florin Covaciu, Alin Burz, Alin Horsia, Pierre Mougenot, Adrian Pîslă, Jefte Nagy, Nicoleta Pop, Ionut Zima, Damien Chablat et al. · 2026 · Mechanisms and machine science
  9. A humanized LIF-targeting antibody synergistically enhances chemo- and immunotherapy in pancreatic cancer
    Fu Xu, Wei Liu, Luying Su, Lang Yang, Yiyao Zhang, BaoQing Liu, Shuaihu Liu, Zuoming Liu, Ziran Chen, Yan Lu et al. · 2026 · Journal of Translational Medicine
  10. MMP7 as a prospective marker of pancreatic carcinoma
    Veronika Roškovičová, Ivana Večurkovská, Jana Kaťuchová, Jana Mašlanková, Péter Bohus, Vladimir Katuch · 2026 · Updates in Surgery
  11. Evaluation of TRAM@PPF Nanoparticles for Efficacy Against Pancreatic Cancer in Mice Model
    Ping Sheng, Liang Zhang, Wenwei Xie, Yu He, Yanjiao Wu, Jinyu Huang, D. Li, Jiafu Leng, Debing Xiang · 2026 · International Journal of Nanomedicine
  12. Evidence that extra copies of chromosome 1q play a role in the early phases of pancreatic neoplasia
    Christopher Blair Douville, Jeeun Parksong, Marco Dal Molin, Sarah Graham, Patricia Theresa Greipp, Ryan A. Knudson, Samuel D. Curtis, Yuxuan Wang, Lisa Dobbyn, Maria Popoli et al. · 2026 · Science Advances
  13. Turning pancreatic cancer from cold to hot: the promise of a p53-expressing oncolytic adenovirus (OBP-702)
    Shinji Kuroda, Hiroshi Tazawa, Masashi Hashimoto, Nobuhiko Kanaya, Yoshihiko Kakiuchi, Shunsuke Kagawa, Yasuo Urata, Toshiyoshi Fujiwara · 2026 · International Journal of Clinical Oncology
  14. Nanomagnetic Hyperthermia Sensitizes Gemcitabine Chemosensitivity in Pancreatic Cancer by Inhibiting HSPB1 to Amplify ACSL4‐Mediated Ferroptosis
    Jiaqiang Ren, Shuai Wu, Tong Su, Hugang Li, Jiachun Ding, Fan Chen, Jiantao Mo, Jin Li, Zheng Wang, Liang Han et al. · 2026 · Small
  15. Markers of immune activation and immunotherapy responsiveness are increased in 3D Pancreatic cancer organoids when primed with photodynamic- and chemo-therapy
    Fernanda V. Cabral, José Quílez-Alburquerque, Madeline JoAnna Szoo, Pushpamali De Silva, Mohammad Ahsan Saad, Tayyaba G. Hasan · 2026 · Translational Oncology
  16. Targeting intratumoral heterogeneity in pancreatic cancer with sequential TIL infusions
    Lucas C. M. Arruda, Julia Karbach, Dragan Kiselicki, Evgueni Sinelnikov, Dirk Gustavus, Hans Hoffmeister, Akin Atmaca, Elke Jäger · 2026 · Cytotherapy
  17. Early cellular plasticity promotes progression and dissemination in pancreatic adenocarcinoma
    Giulio Innamorati, Giorgio Malpeli, Luca Giacomello, Roberto Salvia, Thomas Martin Wilkie · 2026 · Cancer and Metastasis Reviews
  18. Spink1 promotes the survival of Kras-mutant pancreatic acinar cells
    Hidehiro Hayashi, Shin Hamada, Ryotaro Matsumoto, Tetsuya Takikawa, Yan Xu, Ren Jie, Hitomi Nakasuji, Toshiaki Abe, Kazuhiro Kikuta, Hozumi Motohashi et al. · 2026 · Pancreatology
  19. Eph receptors in pancreatic cancer: Biological roles and clinical implications
    Karlijn A. van de Langerijt, Jane Westveen, Geert Kazemier M, Godefridus J. Peters, Tessa Y. S. Le Large, Elisa Giovannetti · 2026 · Critical Reviews in Oncology/Hematology
  20. The impact of tumor location in pancreatic cancer: Survival outcomes after resection in a multi-institutional TriNetX analysis
    Madhu Vishnu Sankar Reddy Rami Reddy, Priyanka Pulvender, Jacob F. Wood, Jianlin Tang · 2026 · The American Journal of Surgery
  21. Non-coding RNAs: modulators of signaling pathways and prognostic biomarkers in digestive system cancer
    Guoming Chen, Yinglan Liang, Ying Yan, Jiayi Zou, Jiayi Zhang, Xiaotong Zeng, Liangman Xiao, Cheng Zhang, Yibin Feng · 2026 · Molecular Cancer
  22. Tumor evolution in an ecological context: How genetic and microenvironmental factors shape the pathogenesis of pancreatic cancer
    Giulia Girolimetti, Grazia Bramato, Alessandro Fiore, Roberta Romanò, Flora Guerra, Cecilia Bucci, Alberto Basset · 2026 · Critical Reviews in Oncology/Hematology
  23. Decoding Drug Resistance in Pancreatic Cancer: A Subcellular Structure Perspective
    Xiaowen Li, Hao Lyu, Yixin Wu, Anyi Chen, Guifang Wu, Rui Zhang, Shuai Xiao, Dong Guo, Qi Zhang, Chaojun Yan et al. · 2026 · Biology
  24. Integrative multimodal transcriptomics identifies a cancer-associated fibroblast membrane signature for predicting prognosis and therapeutic response in pancreatic ductal adenocarcinoma
    Leshi Zhuang, Wei Zhang, Jun Wu, Jian Cao, Liang Feng, Shubo Cao · 2026 · Journal of Molecular Medicine
  25. Exosomal miR-92a-3p promotes pancreatic cancer cells' extravasation by inducing vascular permeability through inhibition of DAB2IP
    Luhan Li, Yanyan Cui, Miao Zhang, Tianyu Shen, Dekun Wang, Xue Mi, Yuying Zhang, Xiaoyue Tan, Alejandro Vaquero, Thomas Braun et al. · 2026 · Cell Death and Disease
  26. Targeting HAS2 to enhance anti-tumor immunity in pancreatic cancer via PD-L1 regulation
    Chuifang Kong, Yanchun Fang, Lili Shen, Zhihua null Shui, Mengjie Lv, Xinyu Zhang, Hu Xu, Xunxia Bao, Pengwei Cao, Wenjing Ding et al. · 2026 · Communications Biology
  27. Metabolic reprogramming and epigenetic regulation: The dual role of lactate and lactylation in pancreatic ductal adenocarcinoma progression and therapeutics
    Xiang Li, Wei Guo, Yihan Xie, Ryan Li, Wenxin Li, H Wang, Ruixia Du, Hong Jiang, Yefu Liu, Zhe Liu · 2026 · Current Molecular Pharmacology
  28. Photodynamic Priming and Minocycline Overcome Chemoresistance by Reprogramming the Pancreatic Tumor Immune Microenvironment In Vivo
    Fernanda V. Cabral, José Quílez-Alburquerque, Olivia Mooradian, Shivendran Vytheswaran, Badri Parshad, Girgis Obaid, Huang‐Chiao Huang, Tayyaba G. Hasan · 2026 · Advanced Science
  29. A multifunctional DNAzyme-nanozyme cascade system for glucose metabolic reprogramming and theranostics of pancreatic cancer
    Siyu Wang, Jiaqiong Wu, Dongdong Zhang, Xiao Li, Jianqiong Pan, Liuqin Teng, Qingao Meng, Chengkai Zhuang, Jiahui Xu, Ting Chen et al. · 2026 · International Journal of Biological Macromolecules
  30. A Novel Microfluidic System for Immunomagnetic Isolation of Pancreatic Cancer CTCs: Plectin-1 and EpCAM as Potential Tumor Markers
    Patrycja Baranowska, Bartłomiej Łuszczuk, Dominik Kołodziejek, Jakub Trzciński, Weronika Świtlik, Michał Skibniewski, Elżbieta Jastrzębska · 2026 · ACS Omega
  31. Mitochondrial double-stranded RNA fuels pancreatic cancer growth via RIG-I/TLR3 inflammation
    Andrew T. Milcarek, Minjeong Yeon, Camilla Esposito, Prerna Kulkarni, Andrew V. Kossenkov, Jozef Madžo, Anneliese M. Faustino, Hsin-Yao Tang, Alessandra Maria Storaci, A. Palleschi et al. · 2026 · Proceedings of the National Academy of Sciences
  32. PTK6 promotes ferroptosis resistance and CD8+ T cell exhaustion in pancreatic tumors via reprogramming glucose and lipid metabolism
    Rui Zheng, Si Wang, Dan Li, Xing Tian, Lifeng Sun, Jiao Wang, Yuchang Wang, Xuyi Pan, Yifan Liang, Zhihang Yang · 2026 · International Immunopharmacology
  33. Artificial intelligence: Catalyzing a new era in pancreatic cancer cure
    Jun Wang, Wenhao Luo, Menggang Zhang, Yuangyang Wang, Liyuan Ye, J U N T A O Qiu, Yueze Liu, Guihu Weng, Tao Liu, Zhe Cao et al. · 2026 · Cancer Letters
  34. Cure probabilities of patients with pancreatic ductal adenocarcinoma in the United States: A Surveillance, Epidemiology, and End Results–based analysis
    Mohamedraed Elshami, Omkar S Pawar, Jordan Michael Winter · 2026 · Surgery
  35. Persistently Elevated Gamma-Glutamyl Transferase and Hepatobiliary Malignancies: A Real-World Cohort Study
    Arkadeep Dhali, Dushyant Singh Dahiya, Abdul Rafae Faisal, Asad Zaman, Fayaz Khan, Jyotirmoy Biswas, Hareesha Rishab Bharadwaj, Saikat Mandal · 2026 · Cancers
  36. Remodeling the pancreatic tumor microenvironment by chemotherapy: New opportunities for combination therapy
    Yuemeng Tang, Xiyuan Luo, F Zhou, Jin Gu, X F Li, Gang Yang, T P Zhang, Lei You · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  37. Spatial Profiling Identified Senescent Cancer-Associated Fibroblasts Localized in the Border Region of Human Pancreatic Ductal Adenocarcinoma
    Yoshiyuki Harada, Atsuhiro Masuda, Takanori Matsuura, Kenji Nagata, Yoshihide Nanno, Atsushi Masamune, Yuzo Kodama, Eiji Hara, Tomonori Matsumoto · 2026 · Cellular and Molecular Gastroenterology and Hepatology
  38. Comparative study on PD-L1/ALK dual-targeted biomimetic exosomes by two preparation approaches in pancreatic cancer
    Chenyu Yuan, Yuchen Shi, Xiaohong Liu, Yelin Zhao, Zhilong Ruan, Liaoxin Luo, Li Zhang, Hongjuan Yao, Liang Li · 2026 · International Journal of Biological Macromolecules
  39. Band engineering of Cu-doped carbon quantum dot/FeOOH Z-type heterojunction for enhanced electrochemiluminescent detection of carbohydrate antigen 19-9
    Xuyang Deng, Xuemin Qin, Zhi Luo, Shenglan Hu, J Li, Biyang Deng · 2026 · Talanta
  40. Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinations
    Giulia Escobar, Marcela Valderrama Maus · 2026 · Molecular Therapy Oncology
  41. Beyond PARP-HDAC inhibition: mechanistic rationale and medicinal chemistry insights from single to shared-target strategies
    Eman M Elkafoury, Shahenda Mahmoud, Kamyar Afarinkia, Mohammed A. M. Salih, Ashraf Kareem El‐Damasy, Mahmoud A. A. Ibrahim, Ahmed M. Shawky, Sharaf E. Sharaf, Othman R. Alzahrani, Laila Abdulmohsen Jaragh-Alhadad et al. · 2026 · Bioorganic Chemistry
  42. Investigation of a GPC1-targeted and LIFU-responsive nanoplatform with ADV effect for visualized chemo-sonodynamic therapy against pancreatic ductal adenocarcinoma
    Bo Ren, Gang Quan, Hanmei Li, Litao Ye, Xin Xie, Jie Yu, Jian Xu, Jingdong Li, Charng Choon Wong · 2026 · Journal of Cancer Research and Clinical Oncology
  43. The Lysosome–Cathepsin Axis in Pancreatic Cancer: Mechanisms of Stromal Remodeling, Immune Evasion, and Therapy Resistance
    Nika Mazej Jeram, Emanuela Senjor, Janko Kos, Milica Perišić Nanut · 2026 · Biomolecules
  44. Integrated single-cell and bulk RNA sequencing reveals regulated necrosis-associated heterogeneity in pancreatic cancer
    Lei Feng, Jianmin Zhang, Zhonghui Zhu · 2026 · Clinical & Translational Oncology
  45. Sequential cryoablation enhances chemotherapeutic efficacy in pancreatic cancer by downregulating TGF-β mediated fibrosis in the sub-lethal zone
    Yukun Cao, Xin Li (51274), Wangang Gong, Jia Tan, Jing Shen, Xinli Zhou · 2026 · Journal of Thermal Biology
  46. Assessing Response and Outcomes to Modern Multiagent Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma
    Paul H. McClelland, Megan A. Satyadi, Ryan P. Johnson, Rosetta Jacob, Jianmin Pan, Jayesh Rai, Shesh Rai, Davendra P. S. Sohal, Olugbenga Olanrele Olowokure, Jordan R. Kharofa et al. · 2026 · Annals of Surgical Oncology
  47. A pH-responsive liposomal nanoplatform for reprogramming lactate metabolism and immunogenic activation in pancreatic cancer
    Yin Zhang, Yuanyuan Shen, Z L Zhang, Mengke Song, Jiajun Zhang, Yixuan Zhang, Jiawei Liang, Hao Wu, Yu Zhao, Z L Zhang et al. · 2026 · Biomaterials
  48. Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for synergistic glutamine metabolism modulation in pancreatic cancer
    Hongrui Fan, Xuwen Li, Haolin Song, Shilin Zhang, Zonghua Tian, Yun Chen, Jingyi Zhou, Shuo Geng, Huiyi Liu, Yiying Wang et al. · 2026 · Biomaterials
  49. T reg cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I–deficient metastatic pancreatic cancer
    Zoe C. Schmiechen, Eduardo Cruz-Hinojoza, Audrey L. Hilk, Madeline A. Ellefson, Alexander K. Tsai, Olivia M. Dres, Liang‐I Kang, Michael J. Geuenich, Jonah Z. Butler, Adam L. Burrack et al. · 2026 · Science Immunology
  50. Early Pancreatic Cancer: Clinical Implications, Workup, and Imaging Findings with Histopathologic Correlation for Personalized Surveillance
    Shintaro Kano, Wataru Gonoi, Moto Nakaya, Shohei Inui, Yudai Nakai, Sota Masuoka, T. Masumoto, Manabu Minami, Ayman H. Gaballah, Osamu Abe · 2026 · Radiographics
  51. Spiky Magnetic Titania Particles for Integrated Exosome Capture and Metabolic Profiling Toward Cancer Diagnosis
    Fenghua Liu, Ximao Lin, Liming Liu, Xiaoxiao Xie, Lingxiao Xue, Kai Li, Zhong Ren, Jiacan Su, Yonghui Deng, Chunhui Deng · 2026 · Small
  52. HRD Score: A Promising Biomarker for Genomic Instability Evaluation for Targeted Treatments Among Pancreatic Cancer Patients
    Xiaoyi Wang, Qingyun Zhang, Yecheng Xu, Wenteng Miao, Baian Tao, Chen Jin, Deliang Fu · 2026 · Technology in Cancer Research & Treatment
  53. Pancreatic cancer burden in China from 1990 to 2023: an analysis based on the global burden of disease study 2023
    Ziyue Wang, Shuai Wang, Guomu Liu, Hao Wu, Yuguo Chen · 2026 · Frontiers in Endocrinology
  54. Breaking barriers: nano-boosted drug delivery systems in overcoming the defenses of pancreatic cancer
    Yujia Wang, Yuxin Zhang, Xueyan Wang, Wei Zhao, Qi Li, Minglu Zhou, Ying Liu, Xiaoli Yi, J Inghorn He, Y P. Li et al. · 2026 · Molecular Cancer
  55. Engineered probiotic Bifidobacterium for tumor-targeted pancreatic cancer therapy
    Jaehyun Lee, Kai-Ting Yang, C. Nowicki, Wei Liu, Kang-Di Li, Emile Z. Naccasha, Zhi-Chen Sun, Yang-Bo Fu, H. Liang, R. Weichselbaum et al. · 2026 · Science Advances
  56. Driving tumor-associated macrophages to a CXCL9Hi/SPP1Low phenotype eliminates pancreatic cancer
    Yen Thi Minh Nguyen, Marc Pfefferlé, Juhyun Oh, G. G. Simpson, S. A. Walker, Shingo Noguchi, Christopher S. Garris, Riley J. Deutsch-Williams, P. Wirapati, Federico De Stefano et al. · 2026 · Cell Reports Medicine
  57. Rewiring glucose metabolism in pancreatic cancer by natural compounds: implications for immune evasion and therapeutic targets
    Nitin Kumar Singh, Varsha Gupta, Maninder Singh, Firoz Ahmad, Adil Husain, Varsha Gupta, Siddhartha Kumar Mishra · 2026 · Molecular Biology Reports
  58. Precision targeting of stromal states in pancreatic cancer: a clinical perspective
    Anna Wolters, Maarten F. Bijlsma, Jai Prakash · 2026 · Trends in cancer
  59. Photodynamic priming enhances anti-PD1 therapy responses in patient-derived pancreatic cancer organoid immune cocultures
    Pushpamali De Silva, Demi Wekking, Joanna Joeun Choe, Madeline D. Kidd, Josie L. Pearce, Dario Missael Rocha Castellanos, Piotr J. Zelga, Russell William Jenkins, Kenneth K. Wang, Vinay Chandrasekhara et al. · 2026 · Frontiers in Immunology
  60. Sensing‐Integrated Patient‐Derived Tumorspheres Predict Chemotherapeutic Efficacy via Local Extracellular pH Dynamics
    Stefania Forciniti, Valentina Onesto, Anna Chiara Siciliano, Helena Iuele, Stefano D’Ugo, Norma Depalma, Cinzia Fasano, Alessandro D’Amuri, Giuseppe Gigli, Marcello Giuseppe Spampinato et al. · 2026 · Small
  61. Evolutionarily Conserved Epigenetic Regulation of Transcriptional Cell States During Vertebrate Pancreatic Tumorigenesis
    Somer M. Matar, Sandra Blázquez Araguás, Andrea Diéguez-Docampo, Xiaoying Liu, Annie Katanga, Jordan E. Magurk, Nicole F. Gallien, Michael J Dong, Maria Lao, Nuray Tezcan et al. · 2026 · Cellular and Molecular Gastroenterology and Hepatology
  62. Ferroptosis in pancreatic ductal adenocarcinoma: Mechanisms, tumor biology, and therapeutic opportunities
    Yangchun Xie, Luting Chen, Yuhua Feng, Tao Hou, Rui Kang, Daolin Tang · 2026 · Cancer Letters
  63. 3D-printed niche-matched GelMA-dECM bioinks rewire lipid metabolic reprogramming and chemosensitization in pancreatic ductal adenocarcinoma
    Biwen Zhu, Tao Yang, Mingyue Chang, Yan Li, Di Wu, Jiashuai Yan, Qingsong Guo, Jian Wan, Yibing Guo, Yuhua Lu · 2026 · Biomaterials
  64. Lactylation Modification and Esophageal Cancer: Research Progress From Hypoxia‐Induced Metabolic Reprogramming to Immune Escape
    Xiaowei Liu, Weizhuang Sun, Changyong Li, Yang Wang · 2026 · The FASEB Journal
  65. Longitudinal Analysis of Matched Patient Biospecimens Reveals Neural Reprogramming of Cancer-Associated Fibroblasts following Chemotherapy in Pancreatic Cancer
    Aylin Z. Henstridge, Peter A. Azorsa, Nandini Arya, Ahmed M. Elhossiny, Padma Kadiyala, Molly Goldwasser, Georgina Branch, Vaibhav Sahai, Nicole Peterson, Jorge D. Machicado et al. · 2026 · Cancer Research
  66. Modeling human tumor evolution in mice
    Dale M. Watt, Louise E. Mitchell, S. Leah Etheridge, Philip D. Dunne, Daniel J. Murphy, Karen Blyth · 2026 · STAR Protocols
  67. Radical Antegrade Modular Pancreatosplenectomy Versus Standard Resection in T3 Body and Tail Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Cohort Study
    Dihang Wu, Zhiyuan Li, Yuhong Pan, Jianlin Lai, Yusheng Shi, Xiaowu Xu, Yifeng Tian, Long Huang, Shi Chen · 2026 · Annals of Surgical Oncology
  68. Oncolytic Effect of Zika Virus in Neuroendocrine Pancreatic Tumors: New Perspectives for Therapeutic Approaches
    Martina Maria Cocco, Claudia Carcione, Vitale Miceli, Rosaria Tinnirello, Cinzia Maria Chinnici, Carmine Carbone, Giovanni Zito, Pier Giulio Conaldi, Gioacchin Iannolo · 2023 · International Journal of Molecular Sciences
  69. Preoperative plasma fibrinogen and C-reactive protein/albumin ratio as prognostic biomarkers for pancreatic carcinoma
    Xiaopeng Chen, Zhaohui Chen, Jianyang Guo, Zhe Xiu, Huangxiang Chen · 2024 · Frontiers in Oncology
  70. Altered centriolar cohesion by CEP250 and appendages impact outcome of patients with pancreatic cancer
    Guido Giordano, Giampiero Cipolletta, Agostino Mellone, Giovanni Puopolo, Luigi Coppola, Elena De Santis, Nicola Rosario Forte, Francesco Napolitano, Francesca Pia Caruso, Paola Parente et al. · 2024 · Pancreatology
  71. A preclinical mouse model of hepatic metastasis to instruct effective treatment modalities
    Arianna Pocaterra, Antonio Citro, Chiara Gnasso, Tamara Canu, Anna Tosi, Antonio Rosato, Antonio Esposito, Lorenzo Piemonti, Anna Mondino · 2024 · Methods in cell biology
  72. Niraparib perturbs autophagosome-lysosome fusion in pancreatic ductal adenocarcinoma and exhibits anticancer potential against gemcitabine-resistant PDAC
    Zehui Yao, Huihui Zhang, Kewei Huang, Gelun Huang, Pu Xi, Lingmin Jiang, Dailei Qin, Fan Chen, Shengping Li, Ran Wei · 2024 · Translational Oncology
  73. HIF-3α Facilitates the Proliferation and Migration in Pancreatic Cancer by Inhibiting Autophagy Through Downregulating TP53INP2
    Xianfei Zhou, Yisheng Ling, Luoshun Huang, Fan Yang, Yang Zhang, Yong Lan · 2024 · Cell Biochemistry and Biophysics
  74. Improved Antitumor Efficiency of N4-Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy
    Dan Wang, Xiaobo Wang, Yan Li, Xiaowei Wang, Xuelei Wang, Juan Su, Apeng Wang, Kai Lv, Mingliang Liu, Guimin Xia · 2024 · International Journal of Nanomedicine
  75. Regulating MYC translation in cancer
    Zainab Hussain, Mara H. Sherman · 2025 · Nature Cell Biology
  76. The pancreatitis-cancer transformation-related factor, human rhomboid family-1, promotes pancreatic cancer progression through the SRC/YAP signaling pathway
    Zhilong Ma, Jie Hua, Miaoyan Wei, Lin Han, Mingwei Dong, Wangcheng Xie, Tingyi Luo, Qingcai Meng, Wei Wang, Zhenshun Song et al. · 2025 · Translational Oncology
  77. The role of LncRNA-MANCR induced by HIF-1α drive the malignant progression of pancreatic cancer by targeting miRNA-494/SIRT1 signaling axis under hypoxic conditions
    Yan Jin, Hao Hu, Yitong Tian, Xu Han, Yu Qiao, Long Cheng, Xiaoyu Guo, Zongwei Wang, Xiaoxu Huang, Xiaoming Wang et al. · 2025 · Cancer Gene Therapy
  78. Boosting Immune Checkpoint Therapy Efficacy of Pancreatic Cancer by Cell‐Anchoring Probiotic
    Jinghao Fan, Fang Wang, Shiyi Chen, Mingkang Liu, Wenping Pan, Wantao Wang, Wenzheng Ma, Yiwen Xian, Yongmiao Chen, Xue Wei et al. · 2025 · Advanced Functional Materials
  79. Computational Repurposing of Natural Compounds from Drimia indica , an Underutilized Medicinal Plant, for Targeting Src‐Mediated Pancreatic Cancer Pathways
    Vivek Shit, Mahesh Kumar Dhakar, Manoj Kumar · 2025 · ChemistrySelect
  80. Endoscopic diagnosis of pancreatic cancer: a narrative review
    Seong Ji Choi · 2025 · Journal of Korean Medical Association
  81. Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in murine pancreatic cancer
    Juanjuan Ye, Futoshi Suizu, Keiko Yamakawa, Hiroyuki Yoneyama, Jiro Kondo, Motohiko Kato, Akira Nishiyama, Naohisa Yahagi, Kyuichi Kadota · 2025 · Scientific Reports
  82. Nanosomal Irinotecan Targeting Pancreatic Cancer Cell Surface Neuraminidase‐1 Sialidase
    Ken Murakami, Yasuhiro Yokoi, Nozomi Hirane, Michiru Otaki, Shin‐Ichiro Nishimura · 2025 · Advanced Healthcare Materials
  83. Protein tyrosine phosphatase 1B in solid tumors: Unraveling its clinical significance
    José Esparza‐López, Alejandro Aranda-Gutierrez, Elizabeth Escobar-Arriaga, Citlali Frayde-Aguilar, María Andrea Jaramillo, Eucario León‐Rodríguez, Marı́a de Jesús Ibarra-Sánchez · 2026 · Revista de investigaci�n Cl�nica
  84. Pyrvinium Pamoate Enhances the Anti-cancer Activities of Gemcitabine in Pancreatic Cancer
    Karabo Serala, Jinming Bai, Sharon Prince · 2024 · Preprints.org
  85. Pancreatic Cancer Management by Pentacyclic Triterpenes
    Abdulaziz M. S. Alqahtani, Sultan F. Kadasah, Mohamed O. Radwan · 2024 · Preprints.org
  86. Active Learning-Driven Discovery and Dynamics Simulation of Novel SQLE Inhibitors with ADMET Analysis and Molecular Modification
    Yunyun Xu, Qiang Wang, GaoQiang Xu, YouJian Xu, Yiping Mou · 2024 · Research Square
  87. Identification and liquid-liquid phase separation-Related Genes Prognosis Model in pancreatic cancer by comprehensive analysis
    Yuan Sun, Anlan Zhang, Yan Li, Tao Hu, Ming Li · 2024 · Research Square
  88. Plasminogen activator inhibitors orchestrate the immunosuppressive tumor microenvironment in pancreatic cancer
    Chiara Falcomatà, Sebastian Rune Nielsen, Maximilian M. Schaefer, Bhavya Singh, Alexander Tepper, Divya Chhamalwan, Hunter T. Potak, Maxime Dhainaut, Gürkan Mollaoglu, Matthew D. Park et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  89. ODFormer: a Virtual Organoid for Predicting Personalized Therapeutic Responses in Pancreatic Cancer
    Jing Xu, Xiaolu Yang, Yunguang Li, Huang Wang, Yikai Li, Shijie Tang, Shiwei Guo, Jiawei Zou, Xiaohan Shi, Zexi Chen et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  90. Oncogenic KRAS regulates secretion of extracellular vesicles and surface membrane charge via regulation of phosphatidylserine in pancreatic cancer
    Kshipra S. Kapoor, Xin Luo, Kaira A. Church, Martin M Bell, Bo Fan, Seoyun Kong, Elena V. Ramirez, Yilin Chen, Fernanda Grande Kugeratski, Sibani Lisa Biswal et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Microenvironmental code of pancreatic ductal adenocarcinoma: The prognostic symphony of budding, matrix and lymphocytes
    Qingqing Zhou, Yimeng Ren, Su-Ming Shi, Tengfei Liu · 2025 · World Journal of Gastrointestinal Oncology
  92. Integrative analysis of genomic and transcriptomic data informs precancer progression in the pancreas
    Kathleen Noller, Jiaying Lai, Daniel Lesperance, Ricky S. Adkins, Ahmed M. Elhossiny, Paola A. Guerrero, Kimal Rajapakshe, Anirban Maitra, Michelle Gwinn Giglio, Anup Mahurkar et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Aspartate Transaminases Are Dispensable for Pancreatic Development and Pancreatic Cancer Progression
    Julia Ugras, Noah S. Nelson, Samuel A. Kerk, Damien Sutton, Lin Lin, Peter Sajjakulnukit, Teresa Dombrowski, Gillian Davidson, Brooke L. Lavoie, Dominik Awad et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  94. A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancer
    Kathryn E. Maraszek, Arwen A. Tisdale, Hunter D. Reavis, Xiaozhuo Liu, Eduardo Cortes Gomez, Alexander A. Dolskiy, Caneta Brown, Daksh Thakkar, Maura Dungan, Anusha Adhikari et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Similarity of oncogenic protein expression in KRAS gene delivery-based rat pancreatic cancer model to that of human pancreatic cancer
    Yuto Tanaka, Kenya Kamimura, Osamu Shibata, Kohei Ogawa, Chiyumi Oda, Hiroyuki Abé, Satoshi Ikarashi, Kazunao Hayashi, Takeshi Yokoo, Toshifumi Wakai et al. · 2023 · Biochemical and Biophysical Research Communications
  96. Corynoxine and corynoxine B enhance the antitumor activity of gemcitabine in Panc-1 cells via ROS-p38 signaling pathway
    Limin Yin, Chaohong Shi, Zhongchen Zhang, Wensheng Wang, Ming Li · 2023 · Indian Journal of Experimental Biology
  97. Correlation between PRSS23 and Prognosis and Immune Regulation in Pancreatic Cancer
    jingjing wang, zhe deng · 2023 · Research Square
  98. Machine learning-enhanced insights into sphingolipid-based prognostication: revealing the immunological landscape and predictive proficiency for immunomotherapy and chemotherapy responses in pancreatic carcinoma
    Ting Shi, Minmin Li, Yabin Yu · 2023 · Frontiers in Molecular Biosciences
  99. Pancreatic cancer: the insidious, deadly malignancy
    Mark Greener · 2023 · Prescriber
  100. To Compare the Stability of Different Clinical Model Frameworks in the Overall Survival Rate and Specific Survival Rate of Patients with Non-Metastatic Pancreatic Head Cancer, Pancreatic Body Cancer and Pancreatic Tail Cancer Based on Machine Learning
    冠宇 吴 · 2023 · Advances in Clinical Medicine